Browsing by Author "Tufan, A."
Now showing 1 - 6 of 6
- Results Per Page
- Sort Options
Publication Covid-19 vaccination of spondyloarthritis patients receiving biological therapy: Real-life data(BMJ Publishing Group, 2022-06-01) Yıldırım, T. Demirci; Akleylek, C.; Cinakli, H.; Yildirim, D.; Hakbilen, S.; Coşkun, B. N.; Okyar, B.; Işık, O. Ozdemir; Sağir, R. Piskin; Apaydin, H.; Gülle, S.; Erez, Y.; İnel, T. Yuce; Yilmaz, N.; Akar, S.; Tufan, A.; Yılmaz, S.; Pehlivan, Yavuz; Cetin, G. Yildirim; Cefle, A.; Koca, S. S.; Erten, S.; Yazici, A.; Dalkılıç, Ediz; Can, G.; Sari, I.; Birlik, M.; Önen, F.; COŞKUN, NEJDET; PEHLİVAN, YAVUZ; DALKILIÇ, HÜSEYİN EDİZ; Uludağ Üniversitesi/Tıp Fakültesi/Ramatoloji Bölümü; JHC-5173-2023; FQP-0451-2022; AAG-7155-2021Publication Disease characteristics of psoriatic arthritis patients may differ according to age at psoriasis onset: Cross-sectional data from the psoriatic arthritis-international database(Clinical & Exper Rheumatology, 2021-05-01) Bilgin, E.; Aydin, S. Z.; Tinazzi, I.; Bayindir, O.; Kimyon, G.; Ozisler, C.; Dogru, A.; ; Aksu, K.; Cetin, G. Yildirim; Yilmaz, S.; Solmaz, D.; Omma, A.; Can, M.; Kucuksahin, O.; Yavuz, S.; Ersozlu, E. D.; Kilic, L.; Tarhan, E. F.; Tufan, M. Aydin; Akyol, L.; Cinar, M.; Erden, A.; Gonullu, E.; Yildiz, F.; Bakirci, S.; Erbasan, F.; Esmen, S. Ergulu; Kucuk, A.; Tufan, A.; Balkarli, A.; Mercan, R.; Erten, S.; Akar, S.; Kasifoglu, T.; Duruoz, T.; Yazisiz, V.; Kalyoncu, U.; Dalkılıç, E.; DALKILIÇ, HÜSEYİN EDİZ; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Romatoloji Anabilim Dalı.ObjectiveTo explore the impact of early versus late-onset psoriasis (PsO) on the disease characteristics of psoriatic arthritis (PsA) in a large-multicentre cohort.MethodsThe data from a multicentre psoriatic arthritis database was analysed. Patients were grouped according to age at psoriasis onset (early onset; 40 years of age, late-onset; 40 years of age) and disease characteristics of the groups were compared by adjusting for BMI and PsA duration, where necessary.ResultsAt the time of analyses, 1634 patients were recruited [62.8% females; early onset 1108 (67.8%); late-onset, 526 (32.2%)]. The late-onset group was more over-weight [66.8% vs. 86.8%, p<0.001; adjusted for age -aOR 1.55 (1.11-2.20; 95% CI)]. The early onset group had more scalp psoriasis at onset (56.7% vs. 43.0%, p<0.001), whereas extremity lesions were more common in the late-onset group (63.8% vs. 74.2%, p<0.001). Axial disease in males and psoriatic disease family history in females were significantly higher in the early onset group [38.0% vs. 25.4%; p=0.005; adjusted for PsA duration -aOR 1.76 (1.19-2.62; 95% CI) / 39.5% vs. 30.1%; p=0.003; OR 1.51 (1.15-1.99; 95% CI), respectively]. Psoriatic disease activity parameters, patient-physician reported outcomes and HAQ-DI scores were similar in both groups.ConclusionClinical features of PsA may be affected by the age at onset of PsO. Different genetic backgrounds in early and late-onset PsO may be driving the differences in psoriasis and PsA phenotypes.Publication Do comorbidities decrease the first tnf-inhibitor retention and treatment response in axial spondyloarthritis patients? Data from Turkbio(BMJ Publishing Group, 2020-06-01) Erez, Y.; Karakaş, A.; Kocaer, S. B.; İnel, T. Yüce; Gülle, S.; Avşar, A. Köken; Uslu, S.; Can, G.; Sarı, I.; Birlik, M.; Dalkılıç, E.; Pehlivan, Y.; Şenel, S.; Akar, S.; Koca, S. S.; Tufan, A.; Yazıcı, A.; Yılmaz, S.; İnanç, N.; Solmaz, D.; Akkoç, N.; Önen, F.; TURKBIO Study Group; DALKILIÇ, HÜSEYİN EDİZ; PEHLİVAN, YAVUZ; Bursa Uludağ Üniversitesi/Tıp Fakültesi.; AAG-8227-2021; JHC-5173-2023Publication The influence of obesity on retention and treatment response of secukinumab in patients with axial spondyloarthritis: Real life data from the Turkbio registry(Bmj Publishing Group, 2020-06-01) Karakaş, A.; Gülle, S.; İnel, T. Yüce; Uslu, S.; Avşar, A. Koken; Kocaer, S. B.; Erez, Y.; Can, G.; Birlik, M.; Yazıcı, A.; Tufan, A.; Dalkıliç, Ediz; Koca, S. S.; Akkoç, N.; Akar, S.; Sarı, I.; Önen, F.; Türkbio Registry Grp; DALKILIÇ, HÜSEYİN EDİZ; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Romatoloji Bölümü; JHC-5173-2023Publication Tofacitinib in rheumatoid arthritis-associated interstitial lung disease: Efficacy and safety analysis from treasure real-life data(Bmj Publishing Group, 2021-06-01) Kalyoncu, U.; Bilgin, E.; Erden, A.; Satis, H.; Tufan, A.; Tekgoz, E.; Ates, A.; Kucuksahin, O.; Yazisiz, V.; Kimyon, G.; Bes, C.; Ertenli, A. I.; Kiraz, S.; Coskun, B. N.; COŞKUN, NEJDET; Yagiz, B.; YAĞIZ, BURCU; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Romatoloji Anabilim Dalı.; 0000-0003-0298-4157; 0000-0002-0866-1503; JQW-5031-2023; AAG-7155-2021Publication Work producivity in rheumatoid arthritis: Analysis from multicenter Turkish study(Bmj Publishing Group, 2015-06-01) Pamuk, O. N.; Çetin, P.; Solmaz, D.; Ertenli, I.; Akar, S.; Karaaslan, Y.; Sarı, R. A.; Aksu, K.; Atagündüz, P.; Şentürk, T.; Cefle, A.; Çobankara, V.; Kobak, S.; Koca, S. S.; Pehlivan, Y.; Tufan, A.; Akyol, L.; Gök, K.; Küçükşahin, O.; Dönmez, S.; Akkoç, N.; PEHLİVAN, YAVUZ; Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı.; AAG-8227-2021